These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33731886)

  • 1. Nuclear expression of DDIT3 distinguishes high-grade myxoid liposarcoma from other round cell sarcomas.
    Baranov E; Black MA; Fletcher CDM; Charville GW; Hornick JL
    Mod Pathol; 2021 Jul; 34(7):1367-1372. PubMed ID: 33731886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA damage-inducible transcript 3 immunohistochemistry is highly sensitive for the diagnosis of myxoid liposarcoma but care is required in interpreting the significance of focal expression.
    Vargas AC; Chan NL; Wong DD; Zaborowski M; Fuchs TL; Ahadi M; Clarkson A; Sioson L; Sheen A; Maclean F; Bonar F; Cheah A; Jones M; Chou A; Gill AJ
    Histopathology; 2021 Jul; 79(1):106-116. PubMed ID: 33465826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DDIT3 Immunohistochemistry Is a Useful Tool for the Diagnosis of Myxoid Liposarcoma.
    Scapa JV; Cloutier JM; Raghavan SS; Peters-Schulze G; Varma S; Charville GW
    Am J Surg Pathol; 2021 Feb; 45(2):230-239. PubMed ID: 32815829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of fluorescence in situ hybridization (FISH) in the diagnosis of myxoid soft tissue neoplasms.
    Downs-Kelly E; Goldblum JR; Patel RM; Weiss SW; Folpe AL; Mertens F; Hartke M; Tubbs RR; Skacel M
    Am J Surg Pathol; 2008 Jan; 32(1):8-13. PubMed ID: 18162764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of NKX2-2 expression in round cell sarcomas and other tumors with EWSR1 rearrangement: imperfect specificity for Ewing sarcoma.
    Hung YP; Fletcher CD; Hornick JL
    Mod Pathol; 2016 Apr; 29(4):370-80. PubMed ID: 26847175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CTAG1B clone EPR13780 versus
    Abdelaziz MM; Tayel HY; Abdel-Bary A; Badawy OM
    J Histotechnol; 2022 Jun; 45(2):56-65. PubMed ID: 34845972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NY-ESO-1 is a sensitive and specific immunohistochemical marker for myxoid and round cell liposarcomas among related mesenchymal myxoid neoplasms.
    Hemminger JA; Iwenofu OH
    Mod Pathol; 2013 Sep; 26(9):1204-10. PubMed ID: 23599152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The utility of fluorescence in situ hybridization (FISH) in determining DNA damage-inducible transcript 3 (DDIT3) amplification in dedifferentiated liposarcomas - an important diagnostic pitfall.
    Kuczkiewicz-Siemion O; Wiśniewski P; Dansonka-Mieszkowska A; Grabowska-Kierył M; Olszewska K; Goryń T; Prochorec-Sobieszek M; Rutkowski P; Szumera-Ciećkiewicz A
    Pathol Res Pract; 2021 Sep; 225():153555. PubMed ID: 34325315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLI1 Immunohistochemistry Distinguishes Mesenchymal Neoplasms With GLI1 Alterations From Morphologic Mimics.
    Parrack PH; Mariño-Enríquez A; Fletcher CDM; Hornick JL; Papke DJ
    Am J Surg Pathol; 2023 Apr; 47(4):453-460. PubMed ID: 36693363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics.
    Hung YP; Fletcher CD; Hornick JL
    Mod Pathol; 2016 Nov; 29(11):1324-1334. PubMed ID: 27443513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DDIT3 gene break-apart as a molecular marker for diagnosis of myxoid liposarcoma--assay validation and clinical experience.
    Narendra S; Valente A; Tull J; Zhang S
    Diagn Mol Pathol; 2011 Dec; 20(4):218-24. PubMed ID: 22089349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of fluorescence in situ hybridization in the diagnosis of 230 mesenchymal neoplasms: an institutional experience.
    Tanas MR; Rubin BP; Tubbs RR; Billings SD; Downs-Kelly E; Goldblum JR
    Arch Pathol Lab Med; 2010 Dec; 134(12):1797-803. PubMed ID: 21128778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review with novel markers facilitates precise categorization of 41 cases of diagnostically challenging, "undifferentiated small round cell tumors". A clinicopathologic, immunophenotypic and molecular analysis.
    Machado I; Yoshida A; Morales MGN; Abrahão-Machado LF; Navarro S; Cruz J; Lavernia J; Parafioriti A; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2018 Jun; 34():1-12. PubMed ID: 29661713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.
    Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R
    Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Well-Differentiated Liposarcoma of the Hypopharynx Exhibiting Myxoid Liposarcoma-like Morphology with MDM2 and DDIT3 Co-Amplification.
    Murshed KA; Abo Samra H; Ammar A
    Head Neck Pathol; 2022 Mar; 16(1):288-293. PubMed ID: 34089125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DUX4 Immunohistochemistry Is a Highly Sensitive and Specific Marker for CIC-DUX4 Fusion-positive Round Cell Tumor.
    Siegele B; Roberts J; Black JO; Rudzinski E; Vargas SO; Galambos C
    Am J Surg Pathol; 2017 Mar; 41(3):423-429. PubMed ID: 27879517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myxoid liposarcoma with cartilaginous differentiation showing
    Suzuki K; Yasuda T; Watanabe K; Hori T; Kanamori M; Kimura T
    Oncol Lett; 2017 Dec; 14(6):6789-6794. PubMed ID: 29181103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAX7 immunohistochemical evaluation of Ewing sarcoma and other small round cell tumours.
    Toki S; Wakai S; Sekimizu M; Mori T; Ichikawa H; Kawai A; Yoshida A
    Histopathology; 2018 Oct; 73(4):645-652. PubMed ID: 29920735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myxoid liposarcoma-associated EWSR1-DDIT3 selectively represses osteoblastic and chondrocytic transcription in multipotent mesenchymal cells.
    Suzuki K; Matsui Y; Higashimoto M; Kawaguchi Y; Seki S; Motomura H; Hori T; Yahara Y; Kanamori M; Kimura T
    PLoS One; 2012; 7(5):e36682. PubMed ID: 22570737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathological significance of NY-ESO-1 expression in the diagnosis of myxoid liposarcoma].
    Hei SM; Wei HJ; Chen H; Wang JG
    Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):225-230. PubMed ID: 30831650
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.